trending Market Intelligence /marketintelligence/en/news-insights/trending/xaxruhwsh1hjsk3acta90w2 content esgSubNav
In This List

Aurinia Pharmaceuticals appoints director

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Aurinia Pharmaceuticals appoints director

Aurinia Pharmaceuticals Inc. appointed Joseph Hagan to the board.

Hagan is president and CEO of Regulus Therapeutics Inc.